GENOMIC BIOMARKER MARKET ANALYSIS

Genomic Biomarker Market, by Indication (Oncology, Cardiovascular diseases, Neurological diseases, and Others), by End User (Hospitals, Diagnostic & Research Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Aug 2021
Code : CMI4578
Pages :168
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Restraints & Challenges:

Stability of genomic biomarker
Less reliability of standalone genomic biomarker-based diagnostic tool

Global Genomic Biomarker Market – Restraints

However, certain drawbacks associated with the utility and analysis of genomic biomarkers is expected to hamper the growth of its market over the forecast period. For instance, according to an article published by the Intestinal Journal in November 2019, some genomic biomarkers such as miRNA present in stool sample cannot be used as a standalone diagnostic tool for the detection of colon cancer, due to concerns regarding stability of biomarker and failure to establish adequate predictive value for the diagnosis of colon cancer.